Champlain Investment Partners’s Vericel Corp VCEL Stock Holding History

Champlain Investment Partners’s Portfolio VCEL Stock Details VCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.6M	Sell	755,828 -59,345	-7%	-$2.14M	0.86%	45
2026 Q1	$26.2M	Sell	815,173 -213,674	-21%	-$7.59M	0.33%	98
2025 Q4	$37M	Buy	1,028,847 +41,248	+4%	+$1.52M	0.38%	95
2025 Q3	$31.1M	Sell	987,599 -9,692	-1%	-$348K	0.23%	125
2025 Q2	$42.4M	Buy	997,291 +383,498	+62%	+$16M	0.3%	116
2025 Q1	$27.4M	Sell	613,793 -9,647	-2%	-$519K	0.2%	133
2024 Q4	$34.2M	Buy	+623,440	New	+$31.6M	0.22%	124

Other funds holding VCEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Champlain Investment Partners's VCEL Position: Q2 2026 in Review

Champlain Investment Partners reduced its Vericel Corp (VCEL) stake by 7.3% in Q2 2026, selling an estimated $2.14M and leaving 755,828 shares worth $33.6M. The position accounts for 0.86% of the portfolio, ranked #45.

Champlain Investment Partners first reported a position in VCEL in Q4 2024 and has held it in 7 quarters since. The position peaked at $42.4M in Q2 2025. 320 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

Champlain Investment Partners held 755,828 shares of Vericel Corp worth $33.6M as of Q2 2026.
Champlain Investment Partners sold 59,345 Vericel Corp shares in Q2 2026, an estimated $2.14M.
Vericel Corp made up 0.86% of Champlain Investment Partners's portfolio in Q2 2026, its #45 holding.
Champlain Investment Partners first reported a position in Vericel Corp in Q4 2024 and has held it in 7 quarters since.
Champlain Investment Partners's Vericel Corp position peaked at $42.4M in Q2 2025.
320 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on Champlain Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.